General Dynamics profit rises 9.5% on sustained defense demand-February 2024-www.financetom.com

General Dynamics profit rises 9.5% on sustained defense demand

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

General Dynamics profit rises 9.5% on sustained defense demand

Apr 24, 2024 4:39 AM

April 24 (Reuters) - General Dynamics ( GD ) reported a

rise in first-quarter profit on Wednesday on sustained demand

for its military equipment amid rising geopolitical tensions.

The U.S. defense contractor reported a quarterly profit of

$799 million, up 9.5% from a year ago.

Previous page： Market Chatter: Nio Receives Regulatory Approval for Third China Factory Next page： Campbell Soup lifts annual net sales forecast as demand recovers

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Market Chatter: Nio Receives Regulatory Approval for Third China Factory

Jun 5, 2024

07:21 AM EDT, 06/05/2024 (MT Newswires) -- Nio (NIO) has received regulatory approval to build a third factory in China, Reuters reported Wednesday, citing three people familiar with the matter. The proposed facility, designed to have an annual capacity of 600,000 vehicles, would bring Nio's annual production capacity to 1 million, Reuters reported. The new plant known as F3 is...

Campbell Soup lifts annual net sales forecast as demand recovers

Jun 5, 2024

June 5 (Reuters) - Campbell Soup ( CPB ) on Wednesday raised its forecast for annual net sales growth, banking on a recovery in demand for its ready-to-eat soups and meals and from its acquisition of Rao's sauce maker Sovos Brands. After several quarters of declines, volumes for the company products showed a sequential improvement this year, helped by Campbell...

Vir Biotechnology Says Mid-Stage Trial for Tobevibart, Elebsiran Show Clinically Significant Efficacy

Jun 5, 2024

07:16 AM EDT, 06/05/2024 (MT Newswires) -- Vir Biotechnology ( VIR ) said Wednesday that preliminary data from a mid-stage trial evaluating its investigational hepatitis therapies tobevibart and elebsiran showed sustained virologic response from the two drugs, suggesting potential efficacy. All six patients of the study achieved clinically significant responses to the hepatitis delta virus, with half of the participants...

Spirit AeroSystems Names Irene Esteves CFO

Jun 5, 2024

07:18 AM EDT, 06/05/2024 (MT Newswires) -- Spirit AeroSystems Holdings ( SPR ) said Wednesday it has named its board member Irene Esteves as the new chief financial officer. Esteves succeeds Mark Suchinski, who stepped down and will remain at the company for a transition period, Spirit AeroSystems ( SPR ) said. Esteves previously served as the CFO of Time...